Eli Lilly to acquire Bothell’s Curevo Vaccine for $1.5 billion

Eli Lilly to acquire Bothell’s Curevo Vaccine for $1.5 billion

The acquisition of Curevo Vaccine, which develops vaccines for shingles and chickenpox, was announced Tuesday.

Original Source

Read the full article at Seattletimes →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.